ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 548,58
0,60%
Dow Jones
38 475,17
-0,30%
DAX
18 057,92
0,21%
Brent Oil
82,80
0,82%
Bitcoin
65 324,56
-1,97%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Northwest Biotherapeutics Inc (QB) (NWBO)

  7. Northwest Biotherapeutics Inc (QB) (NWBO) Actualités

NWBO

Northwest Biotherapeutics (QB) (NWBO)

Northwest Biotherapeutics Inc (QB)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:NWBO
DateHeureSourceTitreSymboleSociété
04/06/202423h11Edgar (US Regulatory)Form 8-K - Current reportUSOTC:NWBONorthwest Biotherapeutics Inc (QB)
03/06/202423h22Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:NWBONorthwest Biotherapeutics Inc (QB)
22/05/202422h13Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsUSOTC:NWBONorthwest Biotherapeutics Inc (QB)
10/05/202423h04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:NWBONorthwest Biotherapeutics Inc (QB)
01/03/202423h04Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405USOTC:NWBONorthwest Biotherapeutics Inc (QB)
02/12/202302h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NWBONorthwest Biotherapeutics Inc (QB)
15/11/202313h19InvestorsHub NewsWireEpazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi ArabiaUSOTC:NWBONorthwest Biotherapeutics Inc (QB)
09/11/202314h00InvestorsHub NewsWireEpazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000USOTC:NWBONorthwest Biotherapeutics Inc (QB)
07/11/202313h29InvestorsHub NewsWireEpazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather DemoUSOTC:NWBONorthwest Biotherapeutics Inc (QB)
06/04/202301h32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NWBONorthwest Biotherapeutics Inc (QB)
13/03/202312h35InvestorsHub NewsWireNightfood, Inc. (OTCQB: NGTF) now in Sonesta International Hotels Multiple BrandsUSOTC:NWBONorthwest Biotherapeutics Inc (QB)
28/02/202322h31Edgar (US Regulatory)Annual Report (10-k)USOTC:NWBONorthwest Biotherapeutics Inc (QB)
07/02/202323h55Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:NWBONorthwest Biotherapeutics Inc (QB)
13/01/202322h34Edgar (US Regulatory)Current Report Filing (8-k)USOTC:NWBONorthwest Biotherapeutics Inc (QB)
23/12/202223h24Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:NWBONorthwest Biotherapeutics Inc (QB)
05/12/202213h01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:NWBONorthwest Biotherapeutics Inc (QB)
01/12/202216h29TipRanksNorthwest Bio Accuses Market Makers of Share Price ManipulationUSOTC:NWBONorthwest Biotherapeutics Inc (QB)
25/11/202223h30Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:NWBONorthwest Biotherapeutics Inc (QB)
09/11/202222h31Edgar (US Regulatory)Quarterly Report (10-q)USOTC:NWBONorthwest Biotherapeutics Inc (QB)
27/09/202215h33InvestorsHub NewsWireAcquisition Completed: Endexx (EDXC)'s HYLA Secures 200k+ Unit Order; 4,500 Puffs per UnitUSOTC:NWBONorthwest Biotherapeutics Inc (QB)
30/06/202223h09Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:NWBONorthwest Biotherapeutics Inc (QB)
12/04/202214h30InvestorsHub NewsWireTNS Issues New Reports on Stocks with Potential Near Term Catalysts and a Feature Green Energy NASDAQ ReportUSOTC:NWBONorthwest Biotherapeutics Inc (QB)
17/03/202213h00InvestorsHub NewsWireTNS Feature Report and Next Gen Tech and Biotech That Could Change Our LivesUSOTC:NWBONorthwest Biotherapeutics Inc (QB)
04/03/202215h11InvestorsHub NewsWireSeeking Alpha - ALYI sees substantial interest for new EV taxi programUSOTC:NWBONorthwest Biotherapeutics Inc (QB)
16/02/202214h00InvestorsHub NewsWireBiopharma Companies Setting up for a Rebound in the Near Term and a New Blockchain Feature ReportUSOTC:NWBONorthwest Biotherapeutics Inc (QB)
15/12/202115h28InvestorsHub NewsWireSA Breaking News - PURA sees 2022 revenue upside potential to $10MUSOTC:NWBONorthwest Biotherapeutics Inc (QB)
05/11/202115h20InvestorsHub NewsWireIQST Has Catalysts On Deck That Expose A Valuation Disconnect of Roughly 100% - Here's Why That Gap Should CloseUSOTC:NWBONorthwest Biotherapeutics Inc (QB)
29/10/202120h31InvestorsHub NewsWireiQSTEL, Inc. - The Calm Before The Surge (OTCQX: IQST)USOTC:NWBONorthwest Biotherapeutics Inc (QB)
29/10/202113h08InvestorsHub NewsWireStar Alliance Intl. Corp. (OTC Pink: STAL) Recent Gold Mine Acquisition NI43-101USOTC:NWBONorthwest Biotherapeutics Inc (QB)
14/10/202117h34InvestorsHub NewsWireIQST - EV & Hi-Tech Company Poised For Potential 4X ROI - Q3 Financials and Short SqueezeUSOTC:NWBONorthwest Biotherapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:NWBO

Dernières Valeurs Consultées

USI
USTECH100
US Tech 100
EU
CAP
Capgemini
COIN
BTCUSD
Bitcoin
EU
AI
Air Liquide
NYSE
KO
Coca Cola
EU
ACA
Credit Agricole
EU
PX4
SBF 120
EU
BNP
BNP Paribas
EU
RNO
Renault
NASDAQ
GOOGL
Alphabet
SPI
SP500
S&P 500
EU
ML
Michelin
NASDAQ
AMZN
Amazon.com
EU
DG
Vinci
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés